GoodRx Holdings (GDRX) Shares Repurchased (2022 - 2026)

GoodRx Holdings' Shares Repurchased history runs 5 years deep, the most recent figure standing at $12.6 million for Q1 2026.

• In Q1 2026, Shares Repurchased fell 85.2% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $129.0 million (up 42.56% YoY), while the FY2025 annual figure was $216.4 million, up 36.22% from the prior year.
• Shares Repurchased came in at $12.6 million for Q1 2026 at GoodRx Holdings, up from $9.4 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $153.2 million in Q1 2024 to a low of $188000.0 in Q4 2024.
• A 5-year average of $41.3 million and a median of $15.3 million in 2022 frame the typical range for Shares Repurchased.
• Across the five-year window, Shares Repurchased tumbled 99.76% in 2024 and jumped 4915.96% in 2025, its largest moves.
• GoodRx Holdings' Shares Repurchased stood at $18.0 million in 2022, then surged by 333.42% to $77.8 million in 2023, then sank by 99.76% to $188000.0 in 2024, then surged by 4915.96% to $9.4 million in 2025, then soared by 33.27% to $12.6 million in 2026.
• According to Business Quant data, Shares Repurchased over the past three periods registered $12.6 million, $9.4 million, and $61.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison